Category: Press Releases

September 4, 2018

Press Releases Start-ups Collaboration between University of Pennsylvania and Precision Biosciences to Develop Genome Editing Therapeutics

  DURHAM, North Carolina, USA, September 04, 2018 – Precision BioSciences...

MORE >
Wall Street and Broad Street signs, color toning applied, New York City, USA.

April 3, 2019

Press Releases Start-ups Precision BioSciences Announces Closing of IPO

Duke start-up, Precision BioSciences, has closed its initial public offering...

MORE >
Laptop showing before and after using Phitonex florescent biomarkers

October 10, 2019

Duke Innovations Press Releases Start-ups Phitonex Announces $2M Seed Funding

Fluorescent Dye Platform Will Enable New Breadth and Depth in...

MORE >
Basking Bioscience Logo, blue and purple head outline with dna helix

December 7, 2020

Duke Innovations Press Releases Start-ups Basking Biosciences, Inc. Completes $5.4M Seed Financing

Funding to support development of the first reversible thrombolytic therapy...

MORE >

March 16, 2022

Press Releases Start-ups Kymeta Corporation Secures Additional $84 Million in Equity Financing

The investment will further enhance, advance, and accelerate Kymeta’s growth...

MORE >

October 3, 2018

Medicine Press Releases MyoKardia Launches Inaugural MyoSeeds™ Research Grants Program to Advance Independent Research in Heart Disease

Program Intended to Accelerate Innovation in the Biology and Underlying...

MORE >

April 10, 2019

Medicine Press Releases Start-ups PhaseBio Receives FDA Breakthrough Therapy Designation

PhaseBio Pharmaceuticals, based in Malvern, Penn. and San Diego, announced that its...

MORE >
Four Points Innovation Logo

December 18, 2019

Featured Stories Press Releases Start-ups Venture Capital Duke University & Deerfield Management Announce Four Points Innovation

 Deerfield Commits up to $130 million to Accelerate Drug Discovery at Duke Through...

MORE >
Tellus Logo

February 8, 2021

Press Releases Start-ups Tellus Therapeutics Awarded NINDS SBIR Funding

$696,000 Phase I award will support drug product formulation and...

MORE >